The company’s Board of Directors has authorized a new two-year $1B share repurchase program which replaces the remainder of the existing program which was announced in May 2023.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
- RVTY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Revvity price target raised to $135 from $130 at Leerink
- Big banks, UnitedHealth report quarterly earnings: Morning Buzz
- Etsy, Enphase downgraded: Wall Street’s top analyst calls
- Barclays upgrades Revvity, says stock ‘checks most of the boxes’